These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Concise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formation. Dirin M; Urban E; Lachmann B; Noe CR; Winkler J Future Med Chem; 2015; 7(13):1657-73. PubMed ID: 26381134 [TBL] [Abstract][Full Text] [Related]
6. Convenient Solid-Phase Attachment of Small-Molecule Ligands to Oligonucleotides via a Biodegradable Acid-Labile P-N-Bond. Kropacheva NO; Golyshkin AA; Vorobyeva MA; Meschaninova MI Molecules; 2023 Feb; 28(4):. PubMed ID: 36838892 [TBL] [Abstract][Full Text] [Related]
7. Bioconjugates for targeted delivery of therapeutic oligonucleotides. Ming X; Laing B Adv Drug Deliv Rev; 2015 Jun; 87():81-9. PubMed ID: 25689735 [TBL] [Abstract][Full Text] [Related]
9. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents. Kim M; Kim DM; Kim KS; Jung W; Kim DE Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327 [TBL] [Abstract][Full Text] [Related]
10. Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo. Watson SR; Chang YF; O'Connell D; Weigand L; Ringquist S; Parma DH Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):63-75. PubMed ID: 10805157 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Floxuridine Oligonucleotide Conjugates Carrying Potential Enhancers of Cellular Uptake. Aviñó A; Clua A; Bleda MJ; Eritja R; Fàbrega C Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073599 [TBL] [Abstract][Full Text] [Related]
12. Chemical strategies for the synthesis of peptide-oligonucleotide conjugates. Lu K; Duan QP; Ma L; Zhao DX Bioconjug Chem; 2010 Feb; 21(2):187-202. PubMed ID: 19856957 [TBL] [Abstract][Full Text] [Related]
13. Recent preclinical and clinical advances in oligonucleotide conjugates. Craig K; Abrams M; Amiji M Expert Opin Drug Deliv; 2018 Jun; 15(6):629-640. PubMed ID: 29727206 [TBL] [Abstract][Full Text] [Related]
14. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics. Lönnberg H Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases. Ossipov DA Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142 [TBL] [Abstract][Full Text] [Related]
18. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules. Hawner M; Ducho C Molecules; 2020 Dec; 25(24):. PubMed ID: 33339365 [TBL] [Abstract][Full Text] [Related]
19. The chemistry and biology of oligonucleotide conjugates. Juliano RL; Ming X; Nakagawa O Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142 [TBL] [Abstract][Full Text] [Related]
20. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics. Menzi M; Lightfoot HL; Hall J Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]